Menu Search
Equities

Leveljump Healthcare Corp

75J:DEU

Leveljump Healthcare Corp

Actions
  • Price (EUR)--
  • Today's Change--
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

LevelJump Healthcare Corp. is a Canada-based company. The Company’s principal business activity is providing radiology services both by providing direct patient images and by providing Teleradiology services. Teleradiology is the process of providing remote off site reading of radiology scans such as computed tomography (CT), magnetic resonance imaging (MRI), ultrasound (US), and X-ray. Hospital staff scan their emergency room patients, then page the Company’s radiologist on call, who can then remotely view, via secured server, the images and diagnose the patient and provide a report back to the hospital. The Company focuses primarily on critical care for urgent and emergency patients. The Company provides telehealth solutions to client hospitals and imaging centers through its Teleradiology division, as well as in-person radiology services through its Independent Healthcare Facilities (IHF's). The Company operates approximately eight IHF’s.

  • Revenue in CAD (TTM)14.90m
  • Net income in CAD-2.09m
  • Incorporated2022
  • Employees--
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		JUMP:CVE since
announced		Transaction
value
Undisclosed Diagnostic Imaging Clinic,Calgary,Alberta(4)Deal completed11 Oct 202311 Oct 2023Deal completed-37.50%4.24m
Data delayed at least 15 minutes, as of May 09 2024.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.